Elevated Risk of Visceral Malignant Neoplasms in Extramammary Paget Disease

JAMA Dermatol. 2023 Oct 1;159(10):1139-1141. doi: 10.1001/jamadermatol.2023.2679.

Authors

Nolan J Maloney¹, Hanqi Yao¹, Sumaira Z Aasi¹, Esther M John^{2

3

4}, Eleni Linos^{1

4}, Nour Kibbi¹

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
² Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
³ Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, California.
⁴ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

PMID: 37647047
PMCID: PMC10469282 (available on 2024-08-30)
DOI: 10.1001/jamadermatol.2023.2679

No abstract available

Plain language summary

This cross-sectional study evaluates the incidence and types of cancers that develop years after an extramammary Paget disease (EMPD) diagnosis.

Publication types

Letter

MeSH terms

Humans
Paget Disease, Extramammary* / diagnosis
Paget Disease, Extramammary* / pathology
Skin Neoplasms* / diagnosis
Skin Neoplasms* / epidemiology
Skin Neoplasms* / pathology